Original Article

Antimicrobial resistance pattern in healthcare-associated infections: investigation of in-hospital risk factors

Abstract

Background and Objectives: Antimicrobial resistance (AMR) is an increasing threat for efficient treatment of infections. Determining the epidemiology of healthcare-associated infections and causative agents in various hospital wards helps appropriate selection of antimicrobial agents.
Materials and Methods: This retrospective study was performed by analyzing antibiograms from March 2017 to March 2018 among patients admitted to the different wards of Imam Khomeini Hospital Complex in Tehran, Iran.
Results: Among 2440 hospital acquired infections, 59.3% were Gram-negative bacilli: E. coli (n = 469, 22.2%), K. pneumoniae (n = 457, 21.7%), Acinetobacter spp. (n = 282, 13.4%), P. aeruginosa (n = 139, 6.6%) and important Gram-positive bacteria were Enterococcus spp. (n = 216, 10.2%), S. aureus (n = 148, 7%), S. epidermidis (n = 118, 5.6). Generally, there was a high antimicrobial resistance in bacterial isolates in this study. Methicillin resistant Staphylococcus aureus (MRSA) was 56.3 % and MRSE 62.9 %. Vancomycin resistant enterococci (VRE) was 60.7%. K. pneumoniae- ESBL was 79.6% and its resistance to carbapenem was 38.4%. E. coli-ESBL was 42% and its resistance to carbapenems was 2.3%. P. aeruginosa resistance to ceftazidime was 74.4%, to fluroquinolones 63.3%, to aminoglycosides 64.8%, to piperacillin tazobactam 47.6% and to carbapenems 62.1%. Acinetobacter baumannii resistance to ceftazidime was 98.7%, to fluroquinolones 97%, to aminoglycosides 95.9%, to ampicillin sulbactam 84%, to carbapenems 96.4% and to colistin 4%.
Conclusion: The study revealed an alarming rate of resistance to the commonly used antimicrobial agents used in treating HAIs. Also the relationship between AMR and some risk factors and thus taking steps towards controlling them have been shown.

1. Mouiche MMM, Moffo F, Akoachere J-FTK, Okah-Nnane NH, Mapiefou NP, Ndze VN, et al. Antimicrobial resistance from a one health perspective in Cameroon: a systematic review and meta-analysis. BMC Public Health 2019;19:1135.
2. Collignon PJ, McEwen SA. One health—its importance in helping to better control antimicrobial resistance. Trop Med Infect Dis 2019;4:22.
3. World Health Organization (2014). Antimicrobial resistance: global report on surveillance. https://apps.who.int/iris/bitstream/handle/10665/112647/WHO_HSE_PED_AIP_2014.2_eng.pdf
4. Chamoun K, Farah M, Araj G, Daoud Z, Moghnieh R, Salameh P, et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis 2016;46:64-70.
5. Tseng S-H, Lee C-M, Lin T-Y, Chang S-C, Chuang Y-C, Yen M-Y, et al. Combating antimicrobial resistance: antimicrobial stewardship program in Taiwan. J Microbiol Immunol Infect 2012;45:79-89.
6. Ziakas PD, Thapa R, Rice LB, Mylonakis E. Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS One 2013;8(9):e75658.
7. Aslam B, Wang W, Arshad M, Khurshid M, Muzammil S, Rasool M, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist 2018;11:1645-1658.
8. Lee AS, Huttner B, Harbarth S. Control of methicillin-resistant Staphylococcus aureus. Infect Dis Clin North Am 2011;25:155-179.
9. van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012;67:2090-2100.
10. Revelas A. Healthcare–associated infections: A public health problem. Niger Med J 2012;53:59-64.
11. Centers for Disease Control and Prevention. CDC/NHSN Surveillance Definitions for Specific Types of Infections. Available at: https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf, Accessed 01/01/2016
12. Tokars JI, Richards C, Andrus M, Klevens M, Curtis A, Horan T, et al. The changing face of surveillance for health care-associated infections. Clin Infect Dis 2004;39:1347-1352.
13. CLSI. Performance standards for antimicrobial susceptibility testing. Available at: https://clsi.org/media/3481/m100ed30_sample.pdf , Accessed 01/01/2016.
14. Afhami S, Seifi A, Hajiabdolbaghi M, Bazaz NE, Hadadi A, Hasibi M, et al. Assessment of device-associated infection rates in teaching hospitals in Islamic Republic of Iran. East Mediterr Health J 2019;25:90-97.
15. Peyvasti VS, Mobarez AM, Shahcheraghi F, Khoramabadi N, Rahmati NR, Doust RH. High-level aminoglycoside resistance and distribution of aminoglycoside resistance genes among Enterococcus spp. clinical isolates in Tehran, Iran. J Glob Antimicrob Resist 2020;20:318-323.
16. Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Cheshmeh MA, Omran DS. A survey on urinary tract infections associated with the three most common uropathogenic bacteria. Maedica (Bucur) 2010;5:111-115.
17. Fenta A, Dagnew M, Eshetie S, Belachew T. Bacterial profile, antibiotic susceptibility pattern and associated risk factors of urinary tract infection among clinically suspected children attending at Felege-Hiwot comprehensive and specialized hospital, Northwest Ethiopia. A prospective study. BMC Infect Dis 2020;20:673.
18. Kim J-M, Park Y-J. Lactobacillus and urine microbiome in association with urinary tract infections and bacterial vaginosis. Urogenit Tract Infect 2018;13:7-13.
19. Storr J, Twyman A, Zingg W, Damani N, Kilpatrick C, Reilly J, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control 2017;6:6.
20. Zhang Y, Du M, Johnston JM, Andres EB, Suo J, Yao H, et al. Incidence of healthcare-associated infections in a tertiary hospital in Beijing, China: results from a real-time surveillance system. Antimicrob Resist Infect Control 2019;8:145.
21. Dong B, Liang D, Lin M, Wang M, Zeng J, Liao H, et al. Bacterial etiologies of five core syndromes: laboratory-based syndromic surveillance conducted in Guangxi, China. PLoS One 2014;9(10): e110876.
22. Blomberg B, Manji KP, Urassa WK, Tamim BS, Mwakagile DS, Jureen R, et al. Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study. BMC Infect Dis 2007;7:43.
23. Pondei K, Fente BG, Oladapo O. Current microbial isolates from wound swabs, their culture and sensitivity pattern at the Niger delta university teaching hospital, Okolobiri, Nigeria. Trop Med Health 2013;41:49-53.
24. Ocan M, Bwanga F, Bbosa GS, Bagenda D, Waako P, Ogwal-Okeng J, et al. Patterns and predictors of self-medication in northern Uganda. PLoS One 2014;9(3): e92323.
25. Mawalla B, Mshana SE, Chalya PL, Imirzalioglu C, Mahalu W. Predictors of surgical site infections among patients undergoing major surgery at Bugando Medical Centre in Northwestern Tanzania. BMC Surg 2011;11:21.
26. Naimi HM, Rasekh H, Noori AZ, Bahaduri MA. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. BMC Infect Dis 2017;17:737.
27. Sader HS, Streit J, Fritsche T, Jones R. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004). Clin Microbiol Infect 2006;12:844-852.
Files
IssueVol 13 No 2 (2021) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v13i2.5978
Keywords
Drug resistance; Cross infection; Methicillin-resistant Staphylococcus aureus; Vancomycin resistant Enterococci; Klebsiella pneumoniae; Escherichia coli
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Emami Meybodi MM, Rahimi Foroushani A, Zolfaghari M, Abdollahi A, Alipour A, Mohammadnejad E, Zare Mehrjardi E, Seifi A. Antimicrobial resistance pattern in healthcare-associated infections: investigation of in-hospital risk factors. Iran J Microbiol. 2021;13(2):178-182.